| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Ren,Guan-Sheng | Chairman | 2.06% | |
| Li,Han-Shen | Director | 1.40% | |
| Pan,Liang-Rong | Director | 0.69% | |
| Xiong,Qiang-Sheng | Director | 0.23% | JIA HUA INVESTMENT CO., LTD. |
| Hong,Rong-Long | Director | 0.23% | JIA HUA INVESTMENT CO., LTD. |
| Ding,Jian-Xing | Director | 0.81% | |
| Hou,Jing-De | Director | 0.07% | |
| Cao,Zhong-Ming | Independent Director | 0.00% | |
| Luo,Jin-Sheng | Independent Director | 0.00% | |
| Lin,Yu-Liang | Independent Director | 0.27% | |
| Ceng,Jian-Chao | Independent Director | 0.00% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 6,815,330 | 4,260,412 | 5,963,157 |
| Operating cost | 4,949,021 | 3,204,930 | 4,509,884 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 1,866,309 | 1,055,482 | 1,453,273 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 1,866,309 | 1,055,482 | 1,453,273 |
| Operating expenses | 1,512,551 | 1,296,472 | 1,298,173 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 353,758 | -240,990 | 155,100 |
| Non-operating income and expenses | 195,295 | 11,951 | 142,640 |
| Net profit (loss) before tax | 549,053 | -229,039 | 297,740 |
| Income tax expense (benefits) | 112,823 | 31,925 | 38,763 |
| Net profit (loss) of ongoing business for the current period | 436,230 | -260,964 | 258,977 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 436,230 | -260,964 | 258,977 |
| Other comprehensive profit (loss), net | 27,030 | 55,741 | 38,067 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 463,260 | -205,223 | 297,044 |
| Net profit (loss) attributable to owners of parent company | 112,888 | -30,958 | 252,658 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 323,342 | -230,006 | 6,319 |
| Comprehensive profit (loss) attributable to owners of parent company | 138,546 | 20,709 | 271,928 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 324,714 | -225,932 | 25,116 |
| Basic earnings per share (yuan) | 0 | 0 | 1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 955,563 | 290,594 | 490,027 |
| Net cash inflows (outflows) from investing activities | -83,491 | -24,956 | -264,873 |
| Net cash inflow (outflow) from financing activities | -282,905 | -837,458 | 306,838 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 17,375 | 14,300 | 50,418 |
| Increase (decrease) in cash and cash equivalents in the current period | 606,542 | -557,520 | 582,410 |
| Beginning balance of cash and cash equivalents | 1,135,479 | 1,692,999 | 1,110,589 |
| Ending balance of cash and cash equivalents | 1,742,021 | 1,135,479 | 1,692,999 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 4,378,878 | 3,493,548 | 4,807,851 |
| Non-current asset | 2,922,789 | 2,935,756 | 2,824,514 |
| Total asset | 7,301,667 | 6,429,304 | 7,632,365 |
| Current liability | 2,015,709 | 1,532,827 | 2,428,694 |
| Non-current liability | 1,689,366 | 1,898,955 | 1,843,688 |
| Total liability | 3,705,075 | 3,431,782 | 4,272,382 |
| share capital | 2,237,009 | 2,136,220 | 2,078,605 |
| Equity - secruity token | - | - | - |
| capital reserve | 296,094 | 261,073 | 284,928 |
| retained earning | 175,534 | 57,444 | 237,545 |
| Other equity | 31,915 | 11,459 | -22,981 |
| Treasury stock | -12,931 | -12,931 | -12,973 |
| Total equity attributable to owners of parent company | 2,727,621 | 2,453,265 | 2,565,124 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 868,971 | 544,257 | 794,859 |
| Total Equity | 3,596,592 | 2,997,522 | 3,359,983 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 126,380 | 850,401 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 1,379,692 | 1,379,692 | 1,384,224 |
| Net asset value per share | 12 | 11 | 12 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| 微型PM2.5感測器採購 | 中央研究院 | 108/07/10 | 6174000.0 | 是 |
| 圖書館閱讀區環境數據感測系統採購案 | 國立中正大學 | 108/07/10 | 670000.0 | 是 |
| 室內微型空氣品質感測器一批 | 國立臺灣大學醫學院附設醫院 | 108/06/06 | 504000.0 | 是 |
